Trademark: 88025130
Word
MADRONA PHARMACEUTICALS
Status
Dead
Status Code
606
Status Date
Monday, September 7, 2020
Serial Number
88025130
Mark Type
4000
Filing Date
Tuesday, July 3, 2018
Published for Opposition
Tuesday, December 10, 2019
Abandoned Date
Monday, September 7, 2020

Trademark Owner History
Madrona Pharmaceuticals - Owner At Publication

Classifications
5 pharmaceutical preparations for treatment of pain, allergies, insomnia, heartburn, high-blood pressure, coughing, fever, colds, diarrhea, constipation, all of the foregoing using dosage forms to make medicines easier to take, manage and monitor; pharmaceutical preparations, namely, unit does capsules sold empty using dosage forms to make medicines easier to take, manage and monitor; pharmaceutical preparations for the treatment of infectious diseases caused by Bacillus anthracis, Bacillus cereus, Bartonella henselae, Bartonella Quintana, Bordetella pertussis, Borrelia burgdorferi, Borrelia garinii, Borrelia afzelii, Borrelia recurrentis, Brucella abortus, Brucella canis, Brucella melitensis, Brucella suis, Campylobacter jejuni, Chlamydia pneumoniae, Chlamydia trachomatis, Chlamydophila psittaci, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Clostridium tetani, Corynebacterium diphtheriae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Francisella tularensis, Haemophilus influenzae, Helicobacter pylori, Legionella pneumophila, Leptospira interrogans, Leptospira santarosai, Leptospira weilii, Leptospira noguchii, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Mycobacterium ulcerans, Mycoplasma pneumoniae, Neisseria gonorrhoeae, Neisseria meningitidis, Pseudomonas aeruginosa, Rickettsia rickettsia, Salmonella typhimurium, Shigella sonnei, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus saprophyticus, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Treponema pallidum, Ureaplasma urealyticum, Vibrio cholerae, Yersinia pestis, Yersinia enterocolitica, or Yersinia pseudotuberculosis using dosage forms to make medicines easier to take, manage and monitor
"PHARMACEUTICALS"

Trademark Events
Sep 8, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 7, 2020
Abandonment - No Use Statement Filed
Feb 4, 2020
Noa E-Mailed - Sou Required From Applicant
Dec 10, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 10, 2019
Published For Opposition
Nov 20, 2019
Notification Of Notice Of Publication E-Mailed
Nov 1, 2019
Law Office Publication Review Completed
Nov 1, 2019
Assigned To Lie
Oct 28, 2019
Approved For Pub - Principal Register
Oct 25, 2019
Teas/Email Correspondence Entered
Oct 24, 2019
Correspondence Received In Law Office
Oct 24, 2019
Teas Request For Reconsideration Received
Apr 24, 2019
Notification Of Final Refusal Emailed
Apr 24, 2019
Final Refusal E-Mailed
Apr 24, 2019
Final Refusal Written
Apr 23, 2019
Teas/Email Correspondence Entered
Apr 22, 2019
Correspondence Received In Law Office
Apr 22, 2019
Teas Response To Office Action Received
Dec 18, 2018
Teas Change Of Correspondence Received
Oct 23, 2018
Notification Of Non-Final Action E-Mailed
Oct 23, 2018
Non-Final Action E-Mailed
Oct 23, 2018
Non-Final Action Written
Oct 23, 2018
Assigned To Examiner
Jul 10, 2018
New Application Office Supplied Data Entered In Tram
Jul 6, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24